Skip to main content

Table 3 bNED rate due to various factors

From: Long-term outcome of early stage prostate cancer treated with brachytherapy analysis after a mean follow-up of 7 years

Factors N (bNED rate, %)
PSA  
 0-20.0 ng/ml 79 (59/76)
 >20.0 ng/ml 60 (25/42)
 p-value 0.028
Gleason score  
 <7 77 (53/69)
 ≥7 65 (31/48)
 p-value 0.137
Clinical stage  
 T1b-T2b 78 (52/67)
 T2c 64 (32/50)
 p-value 0.094
Prostate volume  
 ≥30 ml 74 (40/54)
 <30 ml 70 (44/63)
 p-value 0.740
PPC  
 <50% 81 (56/69)
 ≥50% 58 (28/48)
 p-value 0.006
D 90  
 ≥140 Gy 81 (63/78)
 <140 Gy 52 (17/33)
 p-value 0.009